haloperidol has been researched along with Pervasive Child Development Disorders in 7 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The findings suggest that olanzapine is a promising treatment for children with autistic disorder." | 9.09 | Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. ( Cater, J; Choudhury, MS; Delaney, MA; Malone, RP; Sheikh, RM, 2001) |
| "The findings suggest that olanzapine is a promising treatment for children with autistic disorder." | 5.09 | Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. ( Cater, J; Choudhury, MS; Delaney, MA; Malone, RP; Sheikh, RM, 2001) |
| "The authors hypothesize that tic disorders in individuals with PDD may be a marker for a more positive response to dopamine antagonists like haloperidol." | 1.27 | A treatable language disorder: pharmacological treatment of pervasive developmental disorder. ( Burd, L; Fisher, W; Kerbeshian, J, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikkelsen, EJ | 1 |
| Kurita, H | 1 |
| Alessi, N | 1 |
| Alkhouri, I | 1 |
| Fluent, T | 1 |
| Quinlan, P | 1 |
| Williams, K | 1 |
| Malone, RP | 1 |
| Cater, J | 1 |
| Sheikh, RM | 1 |
| Choudhury, MS | 1 |
| Delaney, MA | 1 |
| Searcy, E | 1 |
| Joshi, PT | 1 |
| Capozzoli, JA | 1 |
| Coyle, JT | 1 |
| Fisher, W | 1 |
| Kerbeshian, J | 1 |
| Burd, L | 1 |
1 review available for haloperidol and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Helping the patient who has pervasive developmental disorder.
Topics: Child; Child Development Disorders, Pervasive; Communication; Diagnosis, Differential; Haloperidol; | 2001 |
1 trial available for haloperidol and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.
Topics: Antipsychotic Agents; Autistic Disorder; Benzodiazepines; Child; Child Development Disorders, Pervas | 2001 |
5 other studies available for haloperidol and Pervasive Child Development Disorders
| Article | Year |
|---|---|
Efficacy of neuroleptic medication in pervasive developmental disorders of childhood.
Topics: Antipsychotic Agents; Child; Child Development Disorders, Pervasive; Chlorpromazine; Double-Blind Me | 1982 |
Brief report: delusional disorder in a male adolescent with high-functioning PDDNOS.
Topics: Adolescent; Adult; Antipsychotic Agents; Autistic Disorder; Child Development Disorders, Pervasive; | 1999 |
Haloperidol decanoate in children.
Topics: Administration, Oral; Antipsychotic Agents; Child; Child Behavior Disorders; Child Development Disor | 2001 |
Low-dose neuroleptic therapy for children with childhood-onset pervasive developmental disorder.
Topics: Behavior Therapy; Child; Child Development Disorders, Pervasive; Drug Administration Schedule; Femal | 1988 |
A treatable language disorder: pharmacological treatment of pervasive developmental disorder.
Topics: Child; Child Development Disorders, Pervasive; Haloperidol; Humans; Language Disorders; Middle Aged; | 1986 |